2021 Infectious Disease: Conquering COVID: Vaccines and Vaccination [IFD21-7702]
January 4, 2021
June 30, 2021
Question Expiration Policy
Each question may be answered for 48 hours after the question is delivered
Learning Objectives
At the end of this program, the learner will be able to:
Explain the concept of vaccine efficacy and its implications for public health
Describe the standard vaccine development process and how Operation Warp Speed has accelerated timelines for vaccine development.
Distinguish between types of COVID-19 vaccines, including mechanisms and adverse effects.
Describe the current and anticipated eligibility of patients for COVID-19 vaccines, in light of limited supply and anticipated phase expansion.
Apply knowledge to recommend COVID-19 vaccines to appropriate recipients, including young and healthy persons without comorbid conditions.
Apply knowledge to recommend COVID-19 vaccines to appropriate recipients, including pregnant women and women who are breastfeeding.
Apply knowledge to recommend COVID-19 vaccines to appropriate recipients, including persons who are immunocompromised.
Apply knowledge to recommend COVID-19 vaccines to appropriate recipients, including persons with histories of severe allergies such as anaphylaxis.
Identify common adverse effects of COVID-19 vaccines and their relative severity.
Apply knowledge to recommend appropriate COVID-19 risk-reduction strategies for people after COVID-19 vaccination, including social distancing and the use of masks to reduce the spread of infection.
Credit Information
AMA PRA Category 1 Credits™: 2.00 credits awarded for answering at least 8 questions .
Non-Physician Attendance: 2.00 credits awarded for answering at least 8 questions .